ArticleThe Journal of antimicrobial chemotherapy2022

Intranasally administered S-MGB-364 displays antitubercular activity and modulates the host immune response to Mycobacterium tuberculosis infection.

Nathan S Kieswetter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.